Koninklijke Philips | PHG - Current Liabilities


Koninklijke Philips reported EUR8.82B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Boston Scientific USD 4.57B 868M Mar/2026
Danaher USD 7.46B 653M Mar/2026
Demant DKK 7.42B 1.63B Dec/2025
Dexcom USD 2.22B 81.3M Mar/2026
Edwards Lifesciences USD 1.41B 404.7M Mar/2026
Fresenius EUR 8.38B 1.18B Dec/2025
General Electric Aerospace USD 40.03B 1.05B Mar/2026
Getinge SEK 15.05B 169M Dec/2024
Globus Medical USD 482.46M 16.04M Mar/2026
GN Store Nord DKK 4.81B 2.5B Mar/2026
Hitachi JPY 7.17T 195.03B Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Koninklijke Philips EUR 8.82B 571.01M Dec/2025
Masimo USD 325.4M 46.2M Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Philips EUR 7.43B 78M Mar/2026
ResMed USD 1.35B 103.1M Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
Steris USD 1.14B 222.7M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Terumo JPY 539.7B 243.4B Dec/2025
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026